alert icon Important Updates + Notice of Vendor Data Event

Coming to a Cleveland Clinic location?
Hillcrest Cancer Center check-in changes
Cole Eye entrance closing
Visitation, mask requirements and COVID-19 information

Notice of Intelligent Business Solutions data event
Learn more

G. Thomas Budd, MD

G. Thomas Budd, MD
  • No ratings
  • 0 Patient Satisfaction Ratings
  • 0 Patient Comments
Department Hematology and Medical Oncology
Primary Location Cleveland Clinic Main Campus
Type of Doctor Adults Only
Languages English
Surgeon No
Locations
Cleveland Clinic Main Campus
Primary Location

Cleveland Clinic Main Campus

Appointment:
216.444.6833
Desk:
216.444.6480
Fax:
216.444.9464
Specialties & Treatments

Treatment & Services

  • Cancer Center
  • Cardio-Oncology Center
  • Chemotherapy
  • Clinical Trials
  • Medical Oncology
  • Musculoskeletal Oncology
View all 6 Treatment & Services +

Specialty in Diseases & Conditions

  • Angiosarcomas
  • Askin’s Tumors
  • Bone Cancer
  • Breast Cancer
  • Cancer
  • Chest Wall Sarcomas
  • Chordomas
  • Clival Chordomas
  • Epithelioid Hemangioendothelioma (EHE)
  • Ewing's Sarcoma
  • Gastrointestinal Stromal Tumors (GIST)
  • Knee Bone Tumor
  • Knee Soft Tissue Tumors
  • Metastatic Breast Cancer
  • Musculoskeletal Neoplasms
  • Musculoskeletal Sarcomas
  • Osteosarcoma
  • Primary Soft Tissue Sarcomas of the Chest Wall
  • Radiation Induced Chest Wall Sarcomas
  • Rare Cancer and Blood Disease Program
  • Rhabdomyosarcoma
  • Sarcoma
  • Soft Tissue Sarcoma
View all 23 Specialties +
Insurance

Insurance

Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans
Biography

About G. Thomas Budd, MD

George Thomas Budd, MD, is a staff physician in the Taussig Cancer Center at Cleveland Clinic. His clinical interests include breast cancer, sarcomas and experimental therapeutics. His research interests are focused on experimental therapies, breast cancer and sarcomas.

Board-certified in internal medicine with a subspecialty in medical oncology, Dr. Budd has authored more than 175 articles, book chapters and textbooks. He is a reviewer for numerous peer-reviewed publications including Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In addition, Dr. Budd is a fellow of the American College of Physicians and a member of the Society of Clinical Oncology and American Association for Cancer Research.

Dr. Budd received his medical degree from the University of Kansas Medical School. He completed his internship, residency, and fellowship in medical oncology at Cleveland Clinic.

Education & Professional Highlights

Education & Professional Highlights

Appointed
1982

Education & Fellowships

Fellowship - Cleveland Clinic
Medical Oncology
Cleveland, OH USA
1982

Residency - Cleveland Clinic
Internal Medicine
Cleveland, OH USA
1980

Medical Education - University of Kansas School of Medicine
Kansas City, KS USA
1977

Professional Highlights

  • Grants.gov ID Number 12301534 Department of Defense
    Primary Immunoprevention of Breast Cancer. 10/1/17–9/30/21
    Role: Partnering Principal Investigator 

    N01-CN-55131-MAO - National Cancer Institute
    Phase I and Pharmacokinetic Trials of Perillyl Alcohol in Patients with a Prior History of Breast Carcinoma
    6/30/95 - 6/29/03 (includes no- cost extension)
    Role: Principal Investigator

    N01-CN-55119-MAO - National Cancer Institute
    Phase I Multiple Dose Safety and Pharmacokinetic Clinical Trial of Sulindac Sulfone
    6/30/95 - 5/15/97
    G. Thomas Budd, Principal Investigator

    5U10 CA004919-47 National Cancer Institute
    Southwest Oncology Group
    10/01/87-12/31/09
    Role: Principal Investigator 

    PO1 - CA48919-01A2, National Cancer Institute
    Biology of Renal Cell Carcinoma
    RM Bukowski, Principal Investigator
    Project 1, Combination Cytokine Therapy
    G. Thomas Budd, Principal Investigator


Certifications

  • Internal Medicine
  • Internal Medicine - Medical Oncology

Specialty Interests

Solid tumors, breast cancer, sarcomas, biologic response modifiers, experimental therapeutics, cancer chemoprevention, clinical trials, medical oncology, cancer

Awards & Honors

  • Lula Zapis Endowed Chair to support Breast Cancer Research

Memberships

  • American Society of Clinical Oncology
  • American Association for Cancer Research
  • Southwest Oncology Group
  • American Medical Association
  • American College of Physicians
Research & Publications

Research & Publications

See publications for G. Thomas Budd, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 3/7/2023, Dr. Budd has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Back to Top